X-65529678-C-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_031206.7(LAS1L):c.715G>T(p.Asp239Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000231 in 1,209,967 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 7 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. D239D) has been classified as Likely benign.
Frequency
Consequence
NM_031206.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
LAS1L | NM_031206.7 | c.715G>T | p.Asp239Tyr | missense_variant | 5/14 | ENST00000374811.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
LAS1L | ENST00000374811.8 | c.715G>T | p.Asp239Tyr | missense_variant | 5/14 | 1 | NM_031206.7 | P2 |
Frequencies
GnomAD3 genomes AF: 0.0000179 AC: 2AN: 111835Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 33995
GnomAD3 exomes AF: 0.0000872 AC: 16AN: 183502Hom.: 0 AF XY: 0.0000883 AC XY: 6AN XY: 67936
GnomAD4 exome AF: 0.0000237 AC: 26AN: 1098132Hom.: 0 Cov.: 31 AF XY: 0.0000193 AC XY: 7AN XY: 363486
GnomAD4 genome AF: 0.0000179 AC: 2AN: 111835Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 33995
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 18, 2021 | The c.715G>T (p.D239Y) alteration is located in exon 5 (coding exon 5) of the LAS1L gene. This alteration results from a G to T substitution at nucleotide position 715, causing the aspartic acid (D) at amino acid position 239 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Wilson-Turner syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 05, 2023 | This sequence change replaces aspartic acid, which is acidic and polar, with tyrosine, which is neutral and polar, at codon 239 of the LAS1L protein (p.Asp239Tyr). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt LAS1L protein function. ClinVar contains an entry for this variant (Variation ID: 577687). This variant has not been reported in the literature in individuals affected with LAS1L-related conditions. This variant is present in population databases (rs750436732, gnomAD 0.06%), and has an allele count higher than expected for a pathogenic variant. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at